Does ENZALUTAMIDE Cause Hypoaesthesia? 522 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 522 reports of Hypoaesthesia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.1% of all adverse event reports for ENZALUTAMIDE.
522
Reports of Hypoaesthesia with ENZALUTAMIDE
1.1%
of all ENZALUTAMIDE reports
28
Deaths
84
Hospitalizations
How Dangerous Is Hypoaesthesia From ENZALUTAMIDE?
Of the 522 reports, 28 (5.4%) resulted in death, 84 (16.1%) required hospitalization, and 3 (0.6%) were considered life-threatening.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 522 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)
Which ENZALUTAMIDE Alternatives Have Lower Hypoaesthesia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE